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Central line-associated bloodstream infections (CLABSIs) are a signifi cant source of morbidity, mortality, and added medical costs for hospitalized children and adults.
1,2 Documentation of these complications in the literature spurred national quality improvement efforts aimed at reducing CLABSIs. These efforts, mainly aimed at decreasing the rates through standardizing practice, resulted in dramatic reductions in CLABSIs among both adults and children. 3, 4 For instance, in a collaborative study in 29 children's hospitals sponsored by the Children's Hospital Association, Miller et al 5 reported a drop in infection rates from 5.2 infections per 1000 line days to 2.3 infections per 1000 line days, with sustained and continuously decreasing rates over 3 years.
Because CLABSIs occur commonly, are potentially preventable, and are harmful to patients, the Centers for Medicare & Medicaid Services (CMS), the Joint Commission, and the Agency for Healthcare Research and Quality (AHRQ) sought to design methods to quantify the number of CLABSIs in individual hospitals for use as measures of quality. AHRQ included the measure "infection due to medical care" in their patient safety indicators (PSIs), which originally identifi ed CLABSIs via administrative data by using a nonspecifi c diagnostic code that included infections associated with any device such as pacemakers, venous lines, and arterial lines. 6 The AHRQ pediatric quality indicators were created in 2006 in response to many issues in PSIs that were not appropriate for children 7 but maintained the use of the nonspecifi c diagnostic code for "infection due to medical care." Both PSIs and pediatric quality indicators had risk adjustment methods that were helpful in comparative reporting. In October 2007 a specifi c International Classifi cation of Diseases, Ninth Revision, Clinical Modifi cation (ICD-9-CM) code (999.31) was created to identify "infections due to central venous catheter," with the intent of more accurately identifying CLABSIs by using administrative data. The code included all venous catheters that were placed centrally, including classically placed central lines such as subclavian and femoral lines, peripherally inserted central lines, and umbilical venous catheters, but specifi cally excluded arterial and peripheral venous catheters that are not threaded into a central venous vessel. 8, 9 In 2008, Medicare initiated a nonpayment policy for hospitalizations with a documented hospital-acquired condition to provide incentives to hospitals to reduce CLABSIs and other iatrogenic conditions in adults. 10 The Patient Protection and Affordable Care Act (ACA) of 2010 mandated that Medi caid adopt a similar nonpayment policy. The Medicaid providerpreventable conditions (PPCs) were created in 2011 by CMS as a set of hospital-acquired complications for which hospitals would not be reimbursed for Medicaid patients.
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There is a lack of data regarding the accuracy of ICD-9-CM code 999.31. Therefore, researchers at 3 children's hospitals began working with the Children's Hos pital Association to compare admi n istrative reporting of CLABSI to infection control clinician reporting of CLABSI to the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN). Although the NHSN reporting is voluntary, all 3 of these hospitals report all CLABSIs into the system. The authors tested the hypothesis that the PPC criteria would identify more CLABSIs than those identifi ed by using the strict NHSN criteria because the NHSN criteria were more restrictive than the PPC criteria. All the children's hospitals involved in the study also report CLABSIs to the NHSN in a similar manner. The children's hospitals' microbiology laboratories all produce automated reports of positive blood culture results. Lists of these results are sent to the infection control professionals, who then review the cultures and the charts of the pati ents identifi ed to judge whether the cultures fulfi ll the standardized NHSN criteria for CLABSI infection (Table 1) . Data for patients discharged in 2010 were also collected from the infection control departments by the investigators in each hospital identifying CLABSIs submitted to the NHSN.
METHODS

Patient discharges from
The number of CLABSIs identifi ed by both methods were entered in a 2 × 2 table and analyzed for sensitivity (ie, the probability that the test result will be positive when the condition is present), specifi city (ie, the probability that the test will be negative when the condition is absent), positive predictive value (ie, the probability that the condition will be present when the test is positive), and negative predictive value (ie, the probability that the condition will be absent when the test is negative). For comparison purposes, hospital CLABSIs identifi ed according to infection control by using the NHSN criteria were used as the standard; identifi cation via ICD-9-CM administrative coding and PPC criteria was the test being examined.
As part of the study, additional chart reviews were done by the 3 investigators on the patients who had been designated as having a CLABSI. For those infections identifi ed according to NHSN criteria, reviews independently documented whether the positive culture results were from a patient with a central line and whether the NHSN criteria were fulfi lled and matched the infection control designation. Reviewers documented when a non-"line-associated" term was used to identify the infection (eg, "bacteremia," "sepsis," "bloodstream infection") in the discharge summary. How ever, because chart review of all clinical notes was not performed, only qualitative statements can be made concerning use of other terms for infection. Patients with a CLABSI identifi ed by using PPC criteria were also reviewed and evaluated as to whether documentation could be found to fulfi ll the NHSN criteria. Descriptive analyses were performed on the identifi ed CLABSIs to better understand patient demographic and clinical characteristics.
RESULTS
Total discharges from the 3 children's hospitals in 2010 were 35 698. The number of CLABSIs reported via ICD-9-CM code 999.31 by using the CMS PPC method was 76. CLABSIs reported by hospital infection control departments and NHSN criteria were 138.
Among the 166 total CLABSIs identifi ed (according to either method) in the study, 48 were identifi ed by both administrative data and infection control, 90 by infection control only, and 28 by administrative data only. Using infection control NHSN reporting as the standard, the analysis illustrates that the CMS PPC method using administrative data was 99.92% specifi c and 34.78% sensitive, with a positive predictive value of 63.16% and a negative predictive value of 99.75% (Table 2 ).
Patients identifi ed as having CLABSIs were remarkably similar, regardless of identifi cation method. The "both administrative and infection control" and "infection control only" groups had more male subjects (56% and 52%, respectively) whereas the "administrative data only" group was equally split. All 3 groups were mainly white (60%, 57%, and 54%, respectively) and had Medicaid (48%, 57%, and 68%) as their most prevalent source of insurance. The median age for all groups was ∼1 year ( Table 3 ). The primary reason for hospitalization was chemotherapy for the "both administrative and infection control" and "infection control only" groups (14% and 12%, res pectively). For the "administrative data only" group, the primary reason for hospitalization was hematologic diagnosis except sickle cell (14%), followed closely by chemotherapy (11%). A majority of patients identifi ed by using all 3 methods were clinically high risk and included those who were immunocompromised (42%, 42%, and 57%), malignancy (25%, 32%, and 43%), cardiac surgery (29%, 28%, and (2) www.hospitalpediatrics.org 11%), and chemotherapy (25%, 28%, and 46%). The median hospital length of stay for these cases was very high (56, 52, and 26 days), and hospital mortality rates ranged from 10% for the "both administrative and infection control" group to 18% for the "administrative data only" group ( Table 4) .
The PPC criteria, with its seemingly more subjective defi nition, did not identify more CLABSIs than the strict NHSN criteria as originally hypothesized. Qualitative review of the medical record revealed 3 major themes associated with the 90 instances of ICD-9-CM undercoding of infection control identifi ed CLABSI. The fi rst is that as part of the hospital's infection control process, positive blood culture results were automatically noted and sent to infection control professionals to review against NHSN criteria; no such trigger exists to assist coders in their infection identifi cation process. Second, physicians directly responsible for the pati ent often used terms such as "sepsis," "bacteremia," or "blood stream infection" in the discharge summaries, not specifi cally noting "line-associated bloodstream infection," which is required for coders to assign ICD-9-CM code 999.31. Third, CLABSIs are counted only once in the administrative record even if a patient has multiple CLABSIs during the hospitalization. In contrast, NHSN reporting captures each CLABSI as a single event; therefore, multiple CLABSI may be captured during a single hospitalization.
Although there were fewer cases identifi ed by using administrative data that were not identifi ed according to NHSN criteria (n = 28), all instances seem related to the NHSN's more restrictive defi nition. Some had to do with timing; for instance, a patient had a line placed while in the hospital, was discharged, and then readmitted a day later with a line infection that was identifi ed before the 48-hour time interval required for NHSN to attribute the CLABSI to that hospitalization. There were also cases in which infections in other body sites ruled out an NHSN CLABSI but were identifi ed as a CLABSI by the treating physicians and coded as such.
DISCUSSION
Our data indicate that administrative reporting of CLABSIs using ICD-9-CM code 999.31 and the CMS PPC method is discordant compared with CLABSIs identifi ed by using NHSN criteria.
Results support previous work that shows most patients with CLABSIs are complex, with immunosuppression from malignancy, transplant, chronic gastrointestinal disease, underlying severe chronic illnesses, severe prematurity, or congenital heart disease who have very long hospitalizations. It is less likely that an acute patient who is otherwise healthy and has a length of stay <7 days will experience a CLABSI. 14 These fi ndings are significant because the CMS PPCs are not risk adjusted, and any comparative reporting may inappropriately represent hospitals with large oncology, transplant, neonatology, or congenital heart programs as having much higher rates compared with acute care hospitals without these programs. Similarly, when establishing CLABSI rates, curren tly available administrative data do not have the ability to eliminate patients without a central line in the denominator or to calculate the number of line days a patient has. Administrative data's inability to standardize infections by device utilization may put hospitals that provide care to complex patients at a disadvantage given that this population of patients may require a high rate of central line use.
Given the similarity in demographic and clinical characteristics of patients identifi ed according to both CLABSI methods, we conjecture that the identifi cation differences are probably due to the identifi cation processes themselves. The NHSN method is objective in that positive blood culture results are automatically reported and reviewed according to strict standardized criteria by infection control clinicians. In contrast to CLABSIs reported in administrative data, there are specifi c exclusions for the time of the infection compared with admission time, whether there is another infection present, and whether the bacterial cause has been suffi ciently documented to fulfi ll NHSN criteria.
Clinicians providing medical treatment to patients use blood culture results to determine therapy; these results are not used to decide whether the patient has a NHSN-defi ned CLABSI. They similarly use terms such as "sepsis," "bacteremia," or "bloodstream infection" in the discharge summaries to describe the patient's condition and treatment and may not specifi cally note that the infection is associated with a central line. However, phrasing identifying the infection as a "line-associated bloodstream infection" is required for hospital medical coders to assign ICD-9-CM 999.31 to the case, and this code is essential for any administrative databased method of identifying CLABSIs, such as the CMS PPCs. Although the current study did not specifi cally collect quantifi able data to support our conjecture, the theory is supported by another study focusing on neonatal infections. 15 Educational programs in the hospital may improve clinician documentation of CLABSIs in discharge summaries, but it is unlikely this method would reach the consistency and objectivity of trained infection control personnel who directly report to the NHSN. Another approach would be to have the infection control professionals docu ment in the chart that criteria for a CLABSI has been fulfi lled, which would then allow the coders to use 999.31. However, this option might be diffi cult to implement because infection control designation of a CLABSI event purposely has been independent of clinical designations by the attending physicians to avoid any possible infl uence on event reporting.
The alternative method for reporting CLABSIs to appropriately document epidemiology and comparative rates is through the NHSN, which is a secure Internet-based surveillance system set up in 2008 for voluntary reporting of Our study does have some potential limitations that are important to discuss. Only 3 children's hospitals participated in this study, which could affect the generalizability of the results. Similar patterns of CLABSI identifi cation by using the 2 methods was seen at each hospital, but it is possible that this pattern would not be present at all children's hospitals in the United States. Research bias could also be present because clinicians at each of the children's hospitals were reviewing their data. A common abstraction form and frequent communications were used to minimize this potential issue and to increase consistency in the chart review process.
Finally, the study compared CLABSIs identifi ed by 2 distinct methods, and the authors assumed that the individuals charged with collecting, reviewing, and entering the information are doing so as specifi ed by their specifi c guidelines. The coding of infections could have been biased by the movement toward pay for performance. Once clinicians and coders knew that there would be fi nancial implications for reported CLABSIs, it is possible that there was a choice to not specifi cally designate and code them. 17 Our research cannot answer that question because we did not survey coders or clinicians to try to ascertain potential bias. However, it should be noted that the study was done on 2010 discharges, and the regulations for withholding payment for Medicaid were not in effect until 2012.
It is our opinion that CLABSI comparisons in facilities that care for children should emphasize use of information reported to the NHSN. Given the impact of CLABSIs in the pediatric population, we feel that the reporting of CLABSIs to the NHSN is preferable with its ability to provide rates per line days versus counts of events which could bias hospitals that have more complex patients with lines in place. Farmer et al 17 advocate for use of the NHSN along with suggestions on how to improve the system, including selective auditing of reports and research access to the data. In an earlier article, Perla et al 18 also support the NHSN but have a number of suggestions to improve reliability and validity of the data. NHSN data are also reported according to patient characteristics, which could help institutions identify certain clinical groups in need of specifi c interventions. Practitioners would also have real-time access to clinical data that could inform them of pathogen patterns, resistance to antibiotics, and to hospitals' best practices. As state Medicaid programs begin to implement policies for nonpayment of CLABSIs, they should be mindful that administrative data alone do not reliably report actual CLABSIs.
